Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic

Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesiv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of immunopathology and pharmacology 2020, Vol.34, p.2058738420941754-2058738420941754
Hauptverfasser:	Ciorba, Andrea, Corazzi, Virginia, Skarżyński, Piotr Henryk, Skarżyńska, Magdalena B, Bianchini, Chiara, Pelucchi, Stefano, Hatzopoulos, Stavros
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral drugs Antiviral agents Antiviral drugs Azithromycin Chloroquine Coronaviruses COVID-19 Hydroxychloroquine Letter to the Editor Lopinavir Ototoxicity Pandemics Severe acute respiratory syndrome coronavirus 2 Side effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.
ISSN:	2058-7384 0394-6320 2058-7384
DOI:	10.1177/2058738420941754